Public offerings

New Name Reflects Company's Strategic Focus on AI and High-Performance Computing Infrastructure NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- BlockchAIn Digital Infrastructure, Inc. (NYSE:AIB) ("BlockchAIn" or the "Company"), a developer and operator of digital infrastructure focused on artificial intelligence ("AI") workloads, today announced that it will change its corporate name to AIB Data Centers Inc., effective June 25, 2026. Trading under the new name will begin on June 26, 2026. The name change reflects the Company's evolution from its historical roots in digital asset infrastructure toward its current strategy of developing and operating next-generation data center infrastructure

Bitmine owns 4.66% of the total ETH coin supply of 120.7 millionBitmine is 93% of the way to the 'Alchemy of 5%' in just 11 monthsBitmine named to Fortune Crypto 100 list for 2026, a definitive ranking of the most influential companies in blockchainBitmine closed on its sale of 3,500,000 shares of 9.50% Series A Perpetual Preferred Stock on June 10, 2026Bitmine's Series A Preferred Stock will trade on the NYSE under the symbol BMNP beginning on June 16, 2026Ethereum continues to benefit from the dual tailwinds of Wall Street tokenizing on the blockchain and from agentic AI systems increasingly needing public and neutral blockchainsBitmine has 4,718,677 staked ETH, representing $8.1 billion a

LAS VEGAS, June 15, 2026 /PRNewswire/ -- BOXABL, the Las Vegas-based technology company focused on transforming the housing industry through factory-built homes, today announces the execution of a representation, import, and distribution agreement with TerraCaita Limited, a company based in Bristol, England. Under the agreement, TerraCaita will represent BOXABL products throughout the United Kingdom, the Channel Islands, Northern Ireland, and the Republic of Ireland. As part of the relationship, BOXABL will provide two Casita units to support display, demonstration, and marketing activities within the region.The agreement marks

ELECTRA AI ("ELECTRA"), the AI Brain for Batteries™ platform, and Iron Horse Acquisition II Corp. (NASDAQ:IRHO) ("Iron Horse") today announced that ELECTRA AI's management will participate in ROTH's 16th Annual London Conference, taking place June 16-18, 2026, at the Four Seasons Hotel London at Park Lane in London, UK. The conference brings together institutional investors and executive management teams across high-growth sectors for one-on-one and small-group meetings. ELECTRA AI's CEO and CFO will be available for meetings with investors throughout the event. To schedule a one-on-one meeting with ELECTRA's management, please contact your ROTH conference representative. About ELECTR

VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) -- General Fusion Inc. ("General Fusion" or the "Company"), a leader in the global race to commercialize fusion energy, today announced that its joint registration statement on Form F-4, as amended (the "Registration Statement"), filed in connection with its proposed business combination with Spring Valley Acquisition Corp. III (NASDAQ:SVAC), a publicly traded special purpose acquisition company ("Spring Valley," or "SVAC"), was declared effective by the Securities and Exchange Commission on June 12, 2026. Spring Valley has set a record date of June 12, 2026 (the "Record Date"), and meeting date of July 6, 2026, for its extraordi

LONDON, Ontario, June 15, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that, further to its previous announcement dated June 10, 2026 of a non-brokered private placement of up to 471,698 common shares (the "Offered Shares") at a price of $15.20 (C$21.20) per Offered Share for gross proceeds of up to US$7,169,810 (C$9,999,734)(the "LIFE Offering"), the Company has filed an amended and restated offering document (the "A

Pattern Group Inc. (NASDAQ:PTRN) ("Pattern"), a leader in accelerating brands on global ecommerce marketplaces leveraging proprietary technology and AI, today announced the launch of a public offering of 8,000,000 shares of Series A common stock to be sold by an entity affiliated with Knox Lane LP, a pre-IPO stockholder of Pattern (the "Selling Stockholder"). In addition, the Selling Stockholder is expected to grant the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Series A common stock. The Selling Stockholder will receive all of the net proceeds from the offering and Pattern will not receive any proceeds. The offering is subject to market conditions, and

LOS ANGELES, June 15, 2026 /PRNewswire/ -- BRC Group Holdings, Inc. (NASDAQ:RILY) ("BRC" or the "Company") today provided supplemental information regarding its indirect economic interest in Space Exploration Technologies Corp. ("SpaceX"), following SpaceX's initial public offering on June 12, 2026 (the "IPO"). The Company discussed this interest in its latest filing on Form 10-Q for the quarterly period ended March 31, 2026 filed on May 7, 2026 and its most recent quarterly earnings call on May 7, 2026. BRC Group Holdings, Inc. (formerly B. Riley Financial, Inc.) Provides Update on SpaceX Carried Interest PositionBetween 2018 and 2021, the Company's wealth management business facilitated cl

- Former CFO of Terns Pharmaceuticals to join Immuneering - - Seasoned public company CFO strengthens team with over 25 years of leadership in biotech – NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (NASDAQ:IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, today announced the appointment of Andrew Gengos as Chief Financial Officer, effective July 16, 2026. Mr. Gengos most recently served as Chief Financial Officer and Head of Corporate Development at Terns Pharmaceuticals, which Merck & Co., Inc. acquired for $6.7 billion. At Immuneering, Mr. Gengos will oversee financial strategy, capital allocation, in

Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ:AAPG, HKEX: 6855)), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel therapies to address unmet medical needs in cancer, announced today that seventeen clinical updates from its core assets were presented at the 31st Congress of the European Hematology Association (EHA2026), including eight poster presentations. The presentati

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (NASDAQ:RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferr

$4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrantsSEATTLE, June 12, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced the closing of its previously announced registered direct offering of 1,363,637 shares (the "Shares") of its common stock, par value $0.18 per share ("Common Stock") (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 1,363,637 shares of Common Stock and short-term Series B warrants to pu

TechCreate Group Ltd. (NYSE:TCGL) ("TechCreate" or the "Company"), a technology consultancy and advanced software solutions provider specializing in payment solutions, cybersecurity, and digital services, provided a statement in light of NYSE American LLC's ("NYSE American") announcement that it intends to commence proceedings to delist TechCreate's Class A ordinary shares from the NYSE American stock exchange and, in the interim, to continue to suspend the Company's shares from trading.Following the NYSE Regulation's June 11, 2026 notice to the Company regarding the intended delisting, the Company has and will continue to consult with its legal counsel and other advisors to evaluate its opt

NEW YORK, June 12, 2026 /PRNewswire/ -- M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) (the "Company"), a special purpose acquisition company, today announced that it has cancelled its extraordinary general meeting of shareholders (the "Meeting") to consider and vote on the previously announced proposed business combination (the "Business Combination") between the Company and ReserveOne, Inc., a Delaware corporation ("ReserveOne"). The Meeting, which was originally scheduled to be held on June 15, 2026, at 11:00 a.m. Eastern Time, and which was later postponed to June 18, 2026 at 12:00 p.m. Eastern Time, has been cancelled by the Company's board of directors and will not occur. The Company has

Wuxi, China, June 12, 2026 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd., (NASDAQ:BYAH) an exempted company with limited liability incorporated under the laws of the Cayman Islands (the "Company"), today announced that it has entered into a securities purchase agreement with several investors for the sales of the Company's securities in a registered direct offering (the "Offering") consisting of up to 1,133,332 of the Company's Class A ordinary shares, par value $0.001 each (the "Shares"), and pre-funded warrants (the "Pre-Funded Warrants") to purchase up to 200,000 Class A ordinary shares (the "Warrant Shares"), at a combined purchase price of $1.50 per Share and Pre-Funded

Issued on behalf of Starfighters Space, Inc. The biggest name in space is trading publicly at last. The real story is the dozens of companies whose moment it also is. CAPE CANAVERAL, Fla., June 12, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — Markets love a headline, and today's is enormous: as reported, SpaceX begins trading on Nasdaq under the ticker SPCX, finally giving public investors a way to own the company that, more than any other, built the modern commercial space age. But the most interesting consequence of a debut this large is rarely the debut itself. It is what happens to everything around it — the way a single, gravitational listing pulls an entire sector into

Inclusion Marks Continued Growth and Performance 15 Months Post-IPO CoreWeave, Inc. (NASDAQ:CRWV), The Essential Cloud for AI™, today announced it has been selected for inclusion to the Nasdaq-100® Index, and is expected to join the index prior to market open on June 22, 2026. The Nasdaq-100 Index includes 100 of the largest non-financial companies listed on the Nasdaq Stock Market and is one of the world's most widely followed indexes. "CoreWeave's inclusion in the Nasdaq-100 reflects both our growth and the emergence of AI as one of the defining technologies of our time," said Michael Intrator, Co-Founder, Chairman and Chief Executive Officer of CoreWeave. "We built the cloud purpos

New York, June 12, 2026 (GLOBE NEWSWIRE) -- Inception Growth Acquisition Limited (NASDAQ:IGTA, the "Company")), a publicly traded special purpose acquisition company, announced today that on June 11, 2026, the Company deposited $12,203.33 into the Company's trust account (the "Trust Account")  in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from June 13, 2026 to July 13, 2026. The purpose of the extension is to provide additional time for the Company to complete a business combination. About Inception Growth Acquisition Limited Inception Growth Acquisition Limited is a blank check company incorporated under

JERSEY CITY, N.J., June 12, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announces the closing of Healthcare Triangle, Inc. (NASDAQ:HCTI) private placement of 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 Million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other offering expenses. The notes mature on December 12, 2026 and, subject to the terms and limitations set forth therein, are convertible at the option of the holder at any time after the six-month anniversary of the original issue date at a co

PLEASANTON, Calif., June 12, 2026 /CNW/ -- Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of a private placement of its 15% original issue discount senior convertible promissory notes in the aggregate principal amount of $4.235 million for aggregate gross proceeds of approximately $3.6 million, before deducting placement agent fees and other related offering expenses. The notes mature on December 12, 2026 and, subject to the terms and limitations set forth therein, are convertible at the option of the holder at any time after the six-month anniversary of the original

SINGAPORE, June 12, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (NASDAQ:CUPR) ("Cuprina" or "the Company"), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today announced that on June 11, 2026 it has regained compliance with the Nasdaq Capital Markets Listing Requirements. As previously disclosed on May 29, 2026, the Company received a Staff Delisting Determinations Letter (the "Staff Determination") indicating that the Company's securities had closed below $1.00 per share for 30 consecutive business days, failing to meet the minimum bid price requirement under Listing Rule 555

XIAMEN, China, June 12, 2026 /PRNewswire/ -- Pop Culture Group Co., Ltd (NASDAQ:CPOP) (the "Company"), today announced that it has entered into a securities purchase agreement with a new fundamental institutional investor for the purchase and sale of 53,333,333 Class A Ordinary Shares of the Company, par value $0.01 per share (the "Shares") or pre-funded warrants in lieu thereof, at an offering price of $0.15 per share in a registered direct offering (the "Offering"). Each pre-funded warrant entitles its holder to purchase one Share. The gross proceeds to the Company from the Offering are estimated to be approximately $8 million before deducting the placement agent's fees and other estimated

LAS VEGAS, June 12, 2026 (GLOBE NEWSWIRE) -- via IBN -- BOXABL today highlighted UFO (Unidentified Folding Object), a conceptual off-world habitation system designed to address one of the most fundamental challenges of space settlement: transporting livable structures beyond Earth efficiently. The concept is showcased in BOXABL's recently released video, "LIVE ON THE MOON (Part 1) — UFO by BOXABL," which outlines a vision for scalable off-world habitation built around compact transport, modular expansion and adaptable settlement design. Inspired by the realities of rocket economics, UFO is designed to minimize launch volume and weight while maximizing usable space after deployment. The c

Issued on behalf of Starfighters Space, Inc.The sector's defining company is trading on the open market for the first time. A frontier that was private for a generation is now, finally, everyone's to own.Baystreet.ca News CommentaryCAPE CANAVERAL, Fla., June 12, 2026 /CNW/ -- Some market days are remembered less for what a stock did than for what they signified. As reported, today is one of them: SpaceX is set to begin trading publicly on NASDAQ under the ticker SPCX, ending a long era in which the most consequential company in the modern space age remained beyond the reach of public investors. Whatever the first day's price action, the deeper event is structural — the orbital economy now ha

Momentus Inc. (NASDAQ:MNTS) ("Momentus" or the "Company") a leading U.S. commercial space firm specializing in satellite solutions, in-space transportation, and orbital infrastructure, today announced that it has entered into securities purchase agreements with new and existing long term institutional investors for the purchase and sale of 1,851,852 shares of its common stock in a registered direct offering priced at-the-market under Nasdaq rules (the "Offering"). The gross proceeds from the Offering are expected to be approximately $25 million, before deducting placement agent fees and other estimated Offering expenses. The closing of the Offering is expected to occur on or about June 15

Redfin reports the massive IPO would create enough wealth for SpaceX employees to buy roughly 40% of all the homes in San Antonio, one of the closest major metros to where the company is headquartered. Or they could buy every single home in McAllen, located just 80 miles away from SpaceX headquarters. Alternatively, they could buy 5% of all homes in the Los Angeles metro, where the company was founded.With the wealth created through SpaceX's massive IPO, current and former employees could hypothetically pool their money to buy an estimated 40% of all homes in San Antonio, according to a new report from Redfin, the real estate brokerage powered by Rocket. San Antonio is the closest major U.S.

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced the closing of the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $180 million. The Rare Pediatric Disease Priority Review Voucher was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket's gene therapy for severe leukocyte adhesion deficiency-I (LAD-I), a rare and life-threatening primary immunodeficiency. As previously reported, before the PRV sale Rocket had cash, cash equivalents and investments of $1

BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced upsized underwritten public offering of 8,933,334 shares of its common stock at a price to the public of $37.50 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,733,333 shares of Enliven's common stock at a price to the public of $37.499 per pre-funded warrant, which represents the per share public offering price of each share of Enliven's common

ARLINGTON, Va., June 11, 2026 /PRNewswire/ -- The AES Corporation (NYSE:AES) ("AES" or the "Company") announced today the pricing of $600 million aggregate principal amount of its 5.200% senior notes due 2029 (the "2029 Notes") and $400 million aggregate principal amount of its 5.750% senior notes due 2033 (the "2033 Notes", together with the 2029 Notes, the "Notes"). The closing of the offering of the Notes is expected to occur, subject to the satisfaction of certain customary closing conditions, on June 16, 2026 (T+3). AES intends to use the net proceeds from the offering to repay existing indebtedness and for general corpora

Belden Inc. (NYSE:BDC) ("Belden" or the "Company"), a leading global supplier of specialty networking solutions, announced today that it has successfully syndicated and priced a new $1.85 billion aggregate principal amount senior secured term loan B due 2033 (the "Facility").The loans under the Facility will be issued at a price equal to 99.75% of their face value (or with an original issue discount of 0.25%) and bear interest at SOFR plus 2.25%, with closing expected concurrent with and subject to the consummation of the Company's previously announced pending acquisition (the "Acquisition") of RUCKUS Networks ("RUCKUS") subject to the satisfaction of customary closing conditions. Belden

DENVER, June 11, 2026 /PRNewswire/ -- Greenland Energy Company (NASDAQ:GLND) ("the Company" or "Greenland Energy"), an oil exploration company focused on East Greenland's Jameson Land Basin, today announced the appointment of Carol Craig to the Company's Board of Directors (the "Board"), effective June 5, 2026. Ms. Craig was appointed as a Class I director to fill the vacancy created by the resignation of Daniel M. McCabe, and will also serve as a member of the Board's Audit Committee. Ms. Craig, 59, is the founder, Chief Executive Officer, and Chair of the Board of Directors of Sidus Space, Inc. (NASDAQ:SIDU), an innovative space and defense technology company offering flexible, cost-effect

Venture Global LNG, Inc. ("Venture Global") announced today that its wholly-owned subsidiary, Venture Global LNG, Inc. (the "Issuer") has closed its offering of $1.125 billion aggregate principal amount of its 6.375% senior secured notes due 2034 (the "2034 Notes") and $1.125 billion aggregate principal amount of its 6.625% senior secured notes due 2036 (the "2036 Notes" and, together with the 2034 Notes, the "Notes"). The Issuer used the gross proceeds from the offering to redeem all of the Issuer's outstanding 8.125% senior secured notes due 2028 (the "Existing 2028 Notes") and used cash on hand to pay the redemption premium and related fees and expenses for the offering and the redemptio

NEW YORK, June 11, 2026 /PRNewswire/ -- Ares Dynamic Credit Allocation Fund, Inc. ("ARDC" or the "Fund") (NYSE:ARDC) announced today the declaration of its distribution for the month of June 2026 of $0.1125 per common share, payable as noted below. The following dates apply to the declared distribution:Ex-Date: June 22, 2026Record Date: June 22, 2026Payable Date: June 30, 2026Per Share Amount: $0.1125Based on the Fund's current share price of $12.56 (as of its close on June 10, 2026), the distribution represents an annualized distribution rate of approximately 10.75% (calculated by annualizing the distribution amount and dividing it by the current price). Information regarding the distributi

Lowers Ciena's interest expense and immediately accretive to Earnings per Share Provides further operational and strategic flexibility Bond hedge and warrant structure raises effective conversion price to $1,000 per share Ciena® Corporation (NYSE:CIEN) (the "Company"), the global leader in high-speed connectivity, today announced that it has closed its previously announced private offering (the "Offering") of $2.875 billion aggregate principal amount of 0.00% convertible senior notes due 2031 (the "Notes"), which includes $375 million aggregate principal amount of Notes issued in connection with the initial purchasers' full exercise of their option (i.e. greenshoe execution). The

MFA Financial, Inc. (NYSE:MFA) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.36 per share of common stock. The dividend will be paid on July 31, 2026, to common stockholders of record on June 30, 2026. MFA Financial, Inc. is a leading specialty finance company that invests in residential mortgage loans, residential mortgage-backed securities and other real estate assets. Through its wholly owned subsidiary Lima One Capital, MFA also originates and services business purpose loans for real estate investors. MFA has distributed over $5.0 billion in dividends to stockholders since its initial public offering in 1998. MFA is an internally mana

HOUSTON, June 11, 2026 /PRNewswire/ -- Western Midstream Partners, LP ("WES" or the "Partnership") (NYSE:WES) today announced it closed the previously announced acquisition of Brazos Delaware II, LLC ("Brazos") for approximately $1.6 billion. Transaction consideration comprised approximately $800 million in cash and approximately $800 million in WES common units. WES issued approximately 19.4 million units based on the volume weighted average WES common unit price at the time the acquisition agreement was signed. The Brazos acquisition expands WES's gathering and processing footprint in the Delaware Basin and aligns with WES's philosophy of only deploying capital that sustains or grows its d

BURLINGAME, Calif., June 11, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has commenced an underwritten public offering of $250.0 million of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of Enliven's common stock. In addition, Enliven intends to grant the underwriters a 30-day option to purchase up to an additional $37.5 million of shares of its common stock. All of the shares of common stock and pre-funded warrants are being offered by

LONDON, Ontario, June 11, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. ("Aduro" or the "Company") (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the closing of its underwritten U.S. and Canadian public offering (the "Public Offering") of 1,028,645 common shares at a price of US$15.20 (C$21.20) per common share for gross proceeds to the Company of US$15,635,404, before deducting underwriting discounts and offering expenses. Canaccord Genuity acted as sole bookrunning manager and representat

Incline Village, Nevada, June 11, 2026 (GLOBE NEWSWIRE) -- Mountain Lake Acquisition Corp ("MLAC"), a special purpose acquisition company, today announced the completion of its previously announced business combination with Avalanche Treasury Corporation ("AVAT") (the "Business Combination"). The shares of Class A common stock of AVAT, the combined company following the Business Combination, will commence trading on the Nasdaq on June 11, 2026, under the ticker symbol "AVAT." The Business Combination was approved by MLAC's shareholders at an extraordinary general meeting in lieu of an annual general meeting of shareholders on June 4, 2026, and all remaining closing conditions of the Busin

CoreWeave, Inc. (Nasdaq: CRWV) ("CoreWeave") announced today that it priced a private offering of $1.25 billion aggregate principal amount of 9.625% senior notes due 2032 and €2 billion aggregate principal amount of 8.500% senior notes due 2032 (collectively, the "Notes"). The Notes will have a maturity date of July 15, 2032. The closing of the offering of the Notes is expected to occur on June 18, 2026, subject to customary closing conditions. The Notes will be issued at par and guaranteed on a senior unsecured basis by certain wholly-owned subsidiaries of CoreWeave. CoreWeave intends to use the proceeds from the offering of the Notes for general corporate purposes, including, without li

- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 - Azora's oral candidate, AT177, is a novel, colon‑targeted AhR agonist rationally engineered to have minimal systemic exposure and designed to mitigate safety concerns with systemically absorbed AhR agonists - $32 million in upfront financing with the potential to receive an additional $32 million under additional milestone tranches - Adial to host a conference call today, June 11, 2026 at 1pm ET GLEN ALLEN, Va. and LOS ANGELES, June 11, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceutica

Concept proposes modular building blocks designed to convert local moon dust into protective habitat shieldingLAS VEGAS, June 11, 2026 /PRNewswire/ -- BOXABL today introduced Rego-Brix, a BOXABL developed, radiation-shielding system designed to address one of the most significant obstacles facing long-duration human habitation beyond Earth: exposure to galactic cosmic radiation. The new concept focuses on utilizing regolith—the loose rock and dust covering the lunar surface—to create modular shielding structures that can surround habitats without requiring large quantities of protective material to be launched from Earth. The c

Issued on behalf of Starfighters Space, Inc.A historic IPO is about to hand the orbital economy its first public price tag — and that single number will echo across every space ticker on the board.BREVARD COUNTY, Fla., June 11, 2026 /CNW/ -- American News Group News Commentary — In private markets, value is whispered. In public markets, it is shouted — printed on a ticker, updated by the second, available to everyone. The commercial space sector is about to make that transition at its very summit. As reported, SpaceX is set to price its initial public offering in this window, ahead of a Nasdaq debut, and the figure it settles on will become the reference point against which the entire sector

North American fleet efficiency improved by ~11% YoY, reaching a record 17.9J/THFurther expanded global operations with hash-to-heat deployment in the Nordic region    SINGAPORE, June 11, 2026 /PRNewswire/ -- Canaan Inc. (NASDAQ:CAN) ("Canaan" or the "Company"), an innovator in crypto mining, today released its unaudited bitcoin mining update for the month ending May 31, 2026. Management Commentary"As we continued to streamline our self-mining portfolio and improve operational efficiency, our mining operations delivered solid results during May," said Nangeng Zhang, chairman and chief executive officer of Canaan. "Our self-mining operations delivered 90 BTC during the month, with an addition

Issued on behalf of Starfighters Space, Inc.When the sector's largest company sets its price, every other space stock suddenly has a number to be measured against. That reckoning is happening now.Baystreet.ca News Commentary CAPE CANAVERAL, Fla., June 11, 2026 /CNW/ -- Markets run on price discovery, and there is no more dramatic example than the moment a long-private giant finally tells the world what it thinks it is worth. As reported, that moment arrives for SpaceX around now, with the company's initial public offering expected to price ahead of its Nasdaq debut. The number it lands on will not just value one company — it will recalibrate how investors value an entire sector, because for

Eightco treasury composition as of June 10, 2026: $90M OpenAI equity (indirect), $18M BeastIndustries equity, 16,278 ETH, 283 million WLD holdings, and $142M cash and equivalents,totaling approximately $406 millionOpenAI announced that it submitted a confidential S-1, setting itself up for an initial publicofferingWorld offers a solution to the 'double human' problem in a world proliferating with deepfakes Eightco provides indirect exposure to some of the most innovative private companies includingOpenAI and Beast IndustriesEASTON, Pa., June 11, 2026 /CNW/ -- Eightco Holdings Inc. (NASDAQ:ORBS) ("Eightco" or the "Company") today provided an update on its total holdings, highlighting its uniq

$4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrantsSEATTLE, June 11, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced that it has entered into a securities purchase agreement with institutional investors for the purchase and sale of 1,363,638 shares (the "Shares") of its common stock, par value $0.18 per share ("Common Stock") (or common stock equivalents in lieu thereof), Series A warrants to purchase up to 1,363,638 shares of Common

ZincFive provides mission-critical battery solutions for the data center and AI infrastructure markets through its proprietary high-power, safe, sustainable nickel-zinc battery chemistry Transaction values ZincFive at $600 million pre-money with a pro forma enterprise value of $752 million Revenue doubled from 2024 to 2025 to approximately $66.9 million, with nearly 2 GW of systems shipped or under contract globally and an approximately $81 million commercial backlog from diversified, blue-chip and hyperscaler customers as of December 31, 2025 $125 million in expected gross proceeds, including approximately $100 million in a committed PIPE and approximately $25 million of cash hel

Fiscal Year 2027 Positioned for Revenue Growth and Accelerating Profitability McGraw Hill, Inc. (NYSE:MH) ("McGraw Hill" or the "Company"), a leading global provider of education solutions for preK-12, higher education and professional learning, today announced financial results for the fiscal fourth quarter 2026 and year-end March 31, 2026. Key Fiscal Year 2026 Financial Highlights Total revenue of $2,102.8 million, an increase of 0.1% year-over-year, driven by strong Higher Education execution, offsetting the anticipated smaller K-12 market opportunity driven by procurement cycles. Re-occurring revenue of $1,541.0 million, an increase of 5.8% year-over-year, representing more th

Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Manufacturer for AI, Cloud, Storage, and 5G/Edge, today announced the pricing of its previously announced series of concurrent equity and equity-linked financing transactions. The gross proceeds of these offerings, together with potential gross proceeds of Supermicro's $1.25 billion at-the-market, or ATM, offering program for the sale of common stock over time, represent a total potential equity raise of $7.0 billion, inclusive of the underwriters' options to purchase additional shares and additional depositary shares for the common stock offering and the depositary shares offering, respectively.

Ignite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology. HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE:COPL) ("Copley"), a special purpose acquisition company and Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"), a leader in pathway-level protein analytics to guide precision oncology, announced today that they have entered into a definitive business combination agreement ("BCA"). Upon the closing of the Combination, Copley and Ignite Proteomics will become wholly owned subsidiaries of a newly formed public holding company, which we intend to name Ignite Proteomics Holdings, Inc. ("PubCo"), and

CoreWeave, Inc. (Nasdaq: CRWV) ("CoreWeave") announced today that it intends, subject to market and other customary conditions, to offer $3.5 billion (or euro equivalents) in aggregate principal amount of dollar-denominated and euro-denominated senior notes due 2032 (collectively, the "Notes") in a private offering. The Notes will be guaranteed on a senior unsecured basis by certain wholly-owned subsidiaries of CoreWeave. CoreWeave intends to use the proceeds from the offering of the Notes for general corporate purposes, including, without limitation, repayment of outstanding indebtedness, and to pay fees, costs and expenses in connection with the offering of the Notes. The Notes and re

ORLANDO, June 11, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. ("PureCycle" or "we," "our" or "us") (NASDAQ:PCT) today announced the pricing of its previously announced underwritten public offerings of $250.0 million aggregate principal amount of its 4.75% convertible senior notes due 2032 (the "notes" and such offering, the "Notes Offering"), and, concurrently, 17,661,388 shares of its common stock, par value $0.001 per share (the "common stock"; such offering, the "Common Stock Offering" and, together with the Notes Offering, the "Offerings"), at a public offering price of $8.21 per share, for aggregate gross proceeds of $395.0 million. In addition, PureCycle has granted (i) the

DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the pricing of an underwritten public offering of 47,619,048 shares of its common stock at a public offering price of $1.05 per share. The aggregate gross proceeds from this offering are expected to be $50 million, before deducting underwriting discounts and commissions and other offering expenses payable by Humacyte. The closing of the offering is expected to occur on or about June 12, 2026, subject to the satisfaction of customary closing conditions. In addition,

COLUMBIA, Mo., June 10, 2026 (GLOBE NEWSWIRE) -- EquipmentShare.com Inc (NASDAQ:EQPT) ("EquipmentShare" or the "Company"), a leader in connected jobsite technology and one of the largest equipment rental providers in the United States, announced the appointment of Damian Giangiacomo and Harley Miller to its Board of Directors (the "Board"), effective June 8, 2026. Mr. Giangiacomo will also serve as a member of the Board's Audit Committee. Following the successful completion of EquipmentShare's initial public offering ("IPO"), Board members Henry Yeagley, who joined the Board in May 2022, and John Weinstein, who joined the Board in December 2024, stepped down in connection with an orderly

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 10, 2026, 11:00 pm CET / 5:00 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issuance of 55,232,558 new shares in connection with its previously announced underwritten public offering in the United States, which included shares sold in a private offering to certain qualified or institutional investors outside the United States, including within the European Union. Share capital: EUR 7,073,687.00 Total number of securities c

New York, NY, June 10, 2026 (GLOBE NEWSWIRE) -- byNordic Acquisition Corporation ("BYNO" or the "Company"), a special purpose acquisition company, announced today that the Company has timely deposited into the Company's trust account (the "Trust Account"), an aggregate of $17,470, in order to extend the period of time the Company has to complete a business combination for an additional one (1) month period, from June 12, 2026 to July 12, 2026 (the "Extension"). The Extension is the eleventh of up to twelve (12) one-month extensions permitted under the August 8, 2025 amendment to the Company's Amended and Restated Certificate of Incorporation that allows the Company's board of directors, i

ORLANDO, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. ("PureCycle" or "we," "our" or "us") (NASDAQ:PCT) today announced that it has commenced underwritten public offerings of $250.0 million aggregate principal amount of its convertible senior notes due 2032 (the "notes" and such offering, the "Notes Offering") and, concurrently, $145.0 million of shares of its common stock, par value $0.001 per share (the "common stock"; such offering, the "Common Stock Offering" and, together with the Notes Offering, the "Offerings"). In addition, PureCycle intends to grant (i) the underwriters in the Notes Offering a 30-day option to purchase up to an additional $37.5 million agg

Jiangsu, China, June 10, 2026 (GLOBE NEWSWIRE) -- Mingteng International Corporation Inc. (NASDAQ:MTEN) (the "Company") today announced the closing of its previously announced registered direct offering of 1,131,004 Class A ordinary shares, par value $0.00005 per share ("Class A Ordinary Shares"), at a purchase price of $2.00 per share, and pre-funded warrants to purchase Class A Ordinary Shares at an original exercise price of $2.00, with $1.99995 of the original exercise price pre-funded at the closing, and a remaining exercise price of $0.00005 per Class A Ordinary Share. The gross proceeds from the offering were approximately $2.26 million, before deducting placement agent fees and o

Business combination transaction with Voyager Acquisition Corp. complete, creating a Nasdaq-listed, innovative biopharmaceutical company focused on next-generation cancer therapies of novel bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs)Strengthened financial position with $27.5 million principal amount senior secured note financing and $50 million share purchase agreement to advance VERAXA's pipeline of oncology drug candidates utilizing its novel BiTAC platformVERAXA recently presented promising data supporting the underlying principle of its novel BiTAC platform technology at the American Association for Cancer Research (AACR) 2026 Annual MeetingVERAXA's common stock